36th week of 2011 patent applcation highlights part 42 |
Patent application number | Title | Published |
20110218317 | POLYESTERS COMPRISING FLUOROVINYLETHER FUNCTIONALIZED AROMATIC MOIETIES - Disclosed are polyesters, particularly poly(trimethylene terephthalate), comprising fluorovinylether functionalized aromatic repeat units, and methods to make the polyester polymers. The polymers are useful for imparting soil resistance to polyesters, particularly in the form of fibers, fabrics, and carpets. | 2011-09-08 |
20110218318 | Composition of Matter - Disclosed are compositions of matter comprising an adipic acid product of formula (1) | 2011-09-08 |
20110218319 | POLYARAMID FILMS COMPRISING FLUOROVINYLETHER FUNCTIONALIZED AROMATIC MOIETIES - Provided are polyaramid polymers and films made from the polymers, comprising repeat units of the condensation product of a fluorovinylether functionalized aromatic diacid chloride and an aromatic diamine, and methods to make the films. | 2011-09-08 |
20110218320 | MODIFIED ZINC SALTS OF C4-8-ALKANEDICARBOXYLIC ACIDS AND USE THEREOF AS A POLYMERIZATION CATALYST - Zinc salts of C | 2011-09-08 |
20110218321 | PROCESSES FOR PRODUCING POLYALKYLENE CARBONATES - Production of polyalkylene carbonates via polymerization of carbon dioxide with at least one epoxide of the general formula (I): | 2011-09-08 |
20110218322 | POLYALKYLENE GLYCOL DERIVATIVE AND PROCESS FOR PRODUCING SAME - An object of the present invention is to provide a process for producing a polyalkylene glycol derivative having such high molecular weight and purity that the derivative can be used in pharmaceutical applications. | 2011-09-08 |
20110218323 | PROCESS FOR PREPARING CYCLIC DIAMINES - The present invention relates to a process for preparing a cyclic diamine, comprising the reaction of at least one cyclic alkene with a gas mixture (G) comprising dinitrogen the subsequent conversion of monoxide to give at least one cyclic ketone and then converting the at least one cyclic ketone to a cyclic diamine. The invention also relates to the use of a cyclic diamine with primary and secondary amine functions thus obtained to prepare polyamides and polyurethanes. | 2011-09-08 |
20110218324 | PREPARING POLYETHER ALCOHOLS - In a process for preparing a polyether alcohol d1) by reaction of a) at least one compound having at least three hydrogen atoms reactive with alkylene oxides and a molecular weight Mn of not more than 600 g/mol with b) an alkylene oxide by using c) a catalyst, said reaction is carried out in the presence of a polyether alcohol d) having a hydroxyl number of 100-800 mg KOH/g and a functionality of 1.5 to 8. | 2011-09-08 |
20110218325 | Inhibitor of Endogenous Human Interferon-Gamma - Inactivated protein derivatives of the hIFN-γ that preserve affinity to the hIFN-γ receptor are useful in the treatment of autoimmune diseases, especially multiple sclerosis. | 2011-09-08 |
20110218326 | PLANT-PROTEIN PRODUCT AND METHOD FOR PREPARING THE SAME - A plant-protein product and the method for preparing the same are provided. The plant-protein product is obtained from a plant-protein raw material which is treated by a single-cell separation technique, and the method for preparing the plant-protein product comprises steps of providing the plant-protein raw material; and treating the plant-protein raw material by the single-cell separation technique to prepare the plant-protein product. | 2011-09-08 |
20110218327 | METHOD FOR PROVIDING A .beta.-LACTOGLOBULIN PRODUCT AND AN a-ENRICHED WHEY PROTEIN ISOLATE - The present invention relates to isolation of whey proteins and the preparation of a whey product and a whey isolate. In particular the present invention relates to the isolation of a β-lactoglobulin product and the isolation of an α-enriched whey protein isolate from whey obtained from an animal. The α-enriched whey protein isolate provided by the present invention is besides from being low in β-lactoglobulin also high in α-lactalbumin and immunoglobulin G. | 2011-09-08 |
20110218328 | TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS - Methods useful for effecting prophylaxis or treatment of amyloidosis, including AA Amyloidosis and AL amyloidosis, by administering peptides comprising neoepitopes, such as AA fragments from a C-terminal region of AA, and antibodies specific for neoepitopes of aggregated amyloid proteins, for example, antibodies specific for the C-terminal region of AA fibrils. Antibodies for inhibition of formation and/or increasing clearance of amyloid deposits in a patient thus effecting prophylaxis or treating amyloid disease. | 2011-09-08 |
20110218329 | ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USES - The present invention relates to at least one novel chimeric, humanized or CDR-grafted anti-IL-6 antibodies derived from the murine CLB-8 antibody, including isolated nucleic acids that encode at least one such anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices. | 2011-09-08 |
20110218330 | Novel triazolo pyrimidine compounds - The present invention relates to a pyrimidine compound (I) useful as a pharmaceutical intermediate, to a process for preparing said pyrimidine compound, to intermediates used in said process, and to the use of said pyrimidine compound in the preparation of pharmaceuticals. | 2011-09-08 |
20110218331 | Method of Preparation of DTPA Crosslinked Hyaluronic Acid Derivatives and Modification of Said Dervivatives - The invention relates to the modification of hyaluronic acid by means of a protonized DTPA bis anhydride in a non-basic polar aprotic solvent in absence of any external base to form crosslinked products. The reaction runs via the formation of a complex and the acylating agent is the hyaluronan co-cation itself, i.e. protonized DTPA bis anhydride. The final crosslinked derivative (linker) comprises three carboxylic groups and three tertiary amines which are capable of complexing various metals effectively. The final DTPA crosslinked hyaluronic acid may also be hydrophobized by means of mono, bis or tris functional alkylating agents. | 2011-09-08 |
20110218332 | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof - The present invention relates generally to the control of body weight of animals including mammals and humans, and more particularly to materials identified herein as modulators of weight, and to the diagnostic and therapeutic uses to which such modulators may be put. In its broadest aspect, the present invention relates to the elucidation and discovery of nucleotide sequences, and proteins putatively expressed by such nucleotides or degenerate variations thereof, that demonstrate the ability to participate in the control of mammalian body weight. The nucleotide sequences in object represent the genes corresponding to the murine and human ob gene, that have been postulated to play a critical role in the regulation of body weight and adiposity. Preliminary data, presented herein, suggests that the polypeptide product of the gene in question function as a hormone. The present invention further provides nucleic acid molecules for use as molecular probes, or as primers for polymerase chain reaction (PCR) amplification, i.e., synthetic or natural oligonucleotides. In further aspects, the present invention provides a cloning vector, which comprises the nucleic acids of the invention; and a bacterial, insect, or a mammalian expression vector, which comprises the nucleic acid molecules of the invention, operatively associated with an expression control sequence. Accordingly, the invention further relates to a bacterial or a mammalian cell transfected or transformed with an appropriate expression vector, and correspondingly, to the use of the above mentioned constructs in the preparation of the modulators of the invention. Also provided are antibodies to the ob polypeptide. Moreover, a method for modulating body weight of a mammal is provided. In specific examples, genes encoding two isoforms of both the murine and human ob polypeptides are provided. | 2011-09-08 |
20110218333 | Internalizing ErbB2 antibodies - This invention provides novel erbB2-binding internalizing antibodies. The antibodies, designated F5 and C1, specifically bind to c-erbB2 antigen and, upon binding, are readily internalized into the cell bearing the c-erbB2 marker. Chimeric molecules comprising the F5 and/or C1 antibodies attached to one or more effector molecules are also provided. | 2011-09-08 |
20110218334 | PHOSPHOROTHIOATE OLIGONUCLEOTIDES AND NON-NUCLEOSIDIC PHOSPHOROTHIOATES AS DELIVERY AGENTS FOR iRNA AGENTS - The invention relates to use of single-stranded phosphorothioate oligonucleotides or non-nucleosidic phosphrothiaote as vehicles or carriers to modulate the biodistribution of iRNA agents. | 2011-09-08 |
20110218335 | EIF2GAMMA GENE AS A DIAGNOSTIC TARGET FOR THE IDENTIFICATION OF FUNGAL AND YEAST SPECIES - The current invention relates to a diagnostic kit for a yeast or fungal species comprising at least one oligonucleotide probe capable of binding to at least a portion of the eIF2y gene or its corresponding mRNA. | 2011-09-08 |
20110218336 | METHOD OF PRODUCING SILANE-MODIFIED CATIONIZED CELLULOSE - A method of producing silane-modified cationized cellulose that has excellent aqueous dispersibility, including: a step (1) of cationizing water-soluble cellulose ether in a presence of alkali in a mixed solvent of a water-compatible organic solvent to obtain slurry comprising cationized cellulose; a step (2) of adding acid to said slurry and neutralizing said alkali; a step (3) of reacting said cationized cellulose obtained after said neutralization with an aminosilane compound and a step (4) of drying the obtained slurry, wherein: drying is conducted in step (4) at 115-160° C. until weight loss on drying is 5% by weight or less, or there is also including a step (5) of adding a water-compatible organic solvent or a mixed solvent of a water-compatible organic solvent and water to the cationized cellulose after the neutralization so that water content in a whole solvent that contacts the cationized cellulose is 10% by mass or less. | 2011-09-08 |
20110218337 | LYOCELL FILAMENT FIBER AND CELLULOSE BASED TIRE CORD - Disclosed are a lyocell filament fiber and a cellulose-based tire cord. The lyocell filament fibers and the cellulose based tire cord have good dimensional stability in a highly humid state and thus the tenacity, the elongation, and the modulus are superior to common cellulose based fibers, such as rayon and so on. Their property maintaining rate at the post manufacturing process is high and the processibility is good. | 2011-09-08 |
20110218338 | 2-AMINOPYRIMIDINE MODULATORS OF THE HISTAMINE H4 RECEPTOR - 2-Aminopyrimidine compounds are described, which are useful as H | 2011-09-08 |
20110218339 | Crystalline polymorph of biopterin and production method thereof - Crystalline solids A to E of biopterin are distinguished from each other by diffraction angle in an X-ray powder diffraction pattern measured using Cu—Kα radiation. The crystalline solid A is characterized by strong peak at 4.6° and peaks at 13.6°, 18.1° and 27.5°; the crystalline solid B is characterized by strong peak at 4.85° and peaks at 2.4°, 13.2°, 18.1° and 27.3°; the crystalline solid C is characterized by strong peak at 5.35° and peaks at 10.8°, 21.9° and 27.3°; the crystalline solid D is characterized by strong peak at 5.1° and peaks at 2.6°, 9.2°, 13.4°, 15.4°, 18.3°, 21.8° and 27.3°; and the crystalline solid E is characterized by strong peaks at 4.5° and 5.8°, and peaks at 10.6°, 15.6°, 20.0°, 20.7°, 23.8° and 27.3°. | 2011-09-08 |
20110218340 | 2-[1-Cyanopropyl)Carbamoyl]-5-Chloromethyl Nicotinic Acids and the Use Thereof in Manufacturing Herbicidal Imidazolinones - 2-[(1-cyanopropyl)carbamoyl]-5-chloromethyl nicotinic acids of formula (I) where Z is hydrogen or halogen; Z | 2011-09-08 |
20110218341 | CHEMICAL COMPOUNDS - The use of a compound of formula I | 2011-09-08 |
20110218342 | BETA-AMINO ACIDS AND METHODS AND INTERMEDIATES FOR MAKING SAME - Disclosed are β-amino acids that are unsubstituted in the β position; that are substituted in the β position with an aryl group; that are substituted in the α position with an aryl group; that bear two substituents in the α position; and/or that are substituted in the α and β positions with groups which, together with the carbon atoms at the α and β positions, form a ring. Also disclosed are methods for making the above-mentioned β-amino acids and other β-amino acids which involve providing an α,β-unsaturated imide; converting the α,β-unsaturated imide to a 2-substituted-isoxazolidin-5-one; and converting the 2-substituted-isoxazolidin-5-one to a β-amino acid. | 2011-09-08 |
20110218343 | SMALL MOLECULE INHIBITORS OF ROTAMASE ENZYME ACTIVITY - This invention relates to neurotrophic compounds having an affinity for FKBP-type immunophilins, their preparation and use as inhibitors of the enzyme activity associated with immunophilin proteins, and particularly inhibitors of peptidyl-prolyl isomerase or rotamase enzyme activity. | 2011-09-08 |
20110218344 | PRODUCTION METHOD OF N-VINYL-2-PYRROLIDONE - A method for producing N-vinyl-2-pyrrolidone by crystallization including: controlling a water content in a feed N-vinyl-2-pyrrolidone solution at an inlet of a crystallizer so as to be not lower than 0.7% by weight and not higher than 10% by weight based on the total weight of the N-vinyl-2-pyrrolidone solution; and supplying the feed N-vinyl-2-pyrrolidone solution to a crystallization process. | 2011-09-08 |
20110218345 | AXIALLY ASYMMETRIC PHOSPHORUS COMPOUND AND PRODUCTION METHOD THEREOF - [Problem to be Solved] To provide an axially asymmetric optically active biarylphosphorus compound that can easily produced without the step of optical resolution which was almost indispensable in conventional methods. | 2011-09-08 |
20110218346 | High Selectivity Hydrogen Bonding Polymeric Adsorbent and its Application on the Separation and Purification of Effective Constituents from Ginkgo Extract - Provided are a kind of high selectivity polymeric adsorbents with amide functional groups based on the hydrogen bonding interaction, which is prepared by adequately swelling a DVB-co-MA copolymer of 6% crosslinking degree as the initial resin with dimethyl formamide, performing an amination reaction by adding a diamine, soaking the dried resultant yellow resin with an acylating agent that is a dianhydride, and performing an acylation reaction to obtain the polymeric adsorbent with amide functional groups of the invention. The polymeric adsorbent of the invention can be used to effectively isolate and purify the active ingredients, i.e., flavones and lactones, from the extract of ginkgo leaf. | 2011-09-08 |
20110218347 | PROCESS FOR THE PREPARATION OF TETRANORLABDANE DERIVATIVES - The present invention concerns a process for the preparation of a compound of formula (I) wherein the dotted line is a single bond and n is 1 or the dotted line is a double bond and n is 0, and wherein the relative configuration is as shown, in the form of any one of its diastereoisomers or enantiomers or mixtures thereof. | 2011-09-08 |
20110218348 | POLYPEPTIDES AND METHODS FOR PRODUCING TRIACYLGLYCEROLS COMPRISING MODIFIED FATTY ACIDS - The present invention relates to methods of producing modified fatty acids comprising a functional group which is a hydroxyl group, an epoxy group, an acetylenic group or a conjugated double bond. For example, seeds, seedoil and methods of making seedoil are provided wherein at least 23% (mol %) of the fatty acid content of the seed or seedoil comprises the functional group. Also provided are novel polypeptides, and polynucleotides thereof, which can be used to produce the modified fatty acids, particularly in transgenic plants and cells suitable for fermentation. | 2011-09-08 |
20110218349 | Method for Producing Alkylene Oxide Addition Products - The invention relates to a method for producing alkylene oxide addition products. The method according to the invention is characterized by (a) contacting ethylene and/or propylene with an oxidizing agent in a first structured reactor (“μ reactor”) and (b) feeding the ethylene oxide and/or propylene oxide so obtained, optionally after purification, to a second structured reactor where it is reacted with a compound having a nucleophilic molecular group. | 2011-09-08 |
20110218350 | GLYCERYL ETHER COMPOUNDS AND THEIR USE - Glyceryl ether compounds prepared by the reaction of glycerol and olefin epoxides are disclosed. The compounds are renewable biomass-based surfactants useful as detergents and emulsifiers in formulations for cleaning, laundry, personal care, cosmetics, and industrial uses. | 2011-09-08 |
20110218351 | METHOD OF PREPARING DISILANOL COMPOUND AND METHOD OF STORING DISILANOL COMPOUND - Disclosed is a method of storing a fluorine-containing disilanol compound represented by the following formula (3) in the presence of a tertiary amine in such an amount that a molar ratio of the tertiary amine to a silanol group of the fluorine-containing disilanol compound ranges from 0.001 to 20, | 2011-09-08 |
20110218352 | METHOD OF MAKING MIXED METAL OXIDE CATALYSTS FOR AMMOXIDATION AND/OR OXIDATION OF LOWER ALKANE HYDROCARBONS - The present invention comprises a method for preparing a mixed oxide catalyst for use in producing acrylonitrile or methacrylonitrile from propane or isobutane by ammoxidation in a gaseous phase via methods of contacting any one of the antimony compound, the molybdenum compound, and the vanadium compound with hydrogen peroxide prior to combining with source compounds for the remaining elements in the catalyst. | 2011-09-08 |
20110218353 | FLUOROVINYL ETHER FUNCTIONALIZED AROMATIC DIESTERS, DERIVATIVES THEREOF, AND PROCESS FOR THE PREPARATION THEREOF - Disclosed are fluorovinyl ether functionalized aromatic diesters and derivatives thereof. The compounds disclosed have utility as functionalized monomers and comonomers in polyesters, polyamides, and the like. It has been found that incorporation of the monomers into polymers provides improved soil resistance to shaped articles produced from the polymers. | 2011-09-08 |
20110218354 | Photoautotrophic Adipogenesis Technology (Phat) - The invention provides an isolated photosynthetic microorganism with an altered lipid profile compared to its wild type or naturally occurring counterpart. The bacterium has been genetically modified such that the lipids produced are amenable to producing biodiesel fuel. Accordingly, such an isolated cyanobacterium contains a fatty acid, the length of which is less than C 16. | 2011-09-08 |
20110218355 | METHOD AND APPARATUS FOR PREPARING ALKYL ESTER FATTY ACID USING FATTY ACID - A method for preparing fatty acid alkyl ester for bio-diesel fuel is disclosed, wherein fatty acid, specifically fatty acid distillate reacts with alcohol. The method does not require the glycerin purification process, and has the superior conversion ratio of fatty acid. The method for preparing fatty acid alkyl ester for bio-diesel fuel comprises the step of carrying out a counter current type esterification reaction of fatty acid and alcohol in each tray of a counter current column reactor at a temperature of 200 to 350 and a pressure of 1 to 35 bar. Here the raw material of the fatty acid is fed to an upper part of the counter current column reactor and the alcohol is fed to a lower part of the counter current column reactor. The counter current column reactor has a number of trays which are installed horizontally to have a number of vertical compartments. Each of the number of trays has an opening part at one end thereof to communicate one compartment with an adjoining compartment. The opening parts of two adjoining trays are alternately installed with each other. | 2011-09-08 |
20110218356 | Carbonylation process catalysed by mordenite supported on inorganic oxides - A process for the preparation of methyl acetate and/or acetic acid by carbonylating dimethyl ether and/or methanol with carbon monoxide in the presence of a catalyst, which catalyst is a H-mordenite bound with a mesoporous binder selected from silicas, aluminas, silica-aluminas, magnesium silicates and magnesium aluminum silicates. | 2011-09-08 |
20110218357 | PROCESSES FOR PREPARING 4-CHLOROBENZENESULFONIC ACID AND 4,4'-DICHLORODIPHENYL SULFONE - The invention relates to a process for preparing 4-chlorobenzenesulfonic acid from 2-chlorobenzenesulfonic acid and/or 3-chlorobenzenesulfonic acid, comprising the conversion of 2-chlorobenzenesulfonic acid and/or 3-chlorobenzenesulfonic acid to 4-chlorobenzenesulfonic acid in the presence of sulfuric acid at a temperature of 100 to 300° C. | 2011-09-08 |
20110218358 | DRYING AGENT AND METHOD FOR FORMING THE SAME - One embodiment of the present invention discloses a drying agent having the formula: [Mg | 2011-09-08 |
20110218359 | PREPARATION OF ETHYLENICALLY UNSATURATED CARBOXYLIC SALTS BY CARBOXYLATION OF ALKENES - A process for preparing an alkali metal or alkaline earth metal salt of an α,β-ethylenically unsaturated carboxylic acid, wherein a) an alkene, carbon dioxide and a carboxylation catalyst are converted to an alkene/carbon dioxide/carboxylation catalyst adduct, b) the adduct is decomposed to release the carboxylation catalyst with an auxiliary base to give the auxiliary base salt of the α,β-ethylenically unsaturated carboxylic acid, c) the auxiliary base salt of the α,β-ethylenically unsaturated carboxylic acid is reacted to release the auxiliary base with an alkali metal or alkaline earth metal base to give the alkali metal or alkaline earth metal salt of the α,β-ethylenically unsaturated carboxylic acid. Salts of α,β-ethylenically unsaturated carboxylic acids, such as sodium acrylate in particular, are required in large amounts, for example, for production of water-absorbing resins. | 2011-09-08 |
20110218360 | PREPARATION OF RASAGILINE AND SALTS THEREOF - The present invention relates to processes for the preparation of rasagiline mesylate. Also provided is rasagiline mesylate having 90 volume percent of the particles (D | 2011-09-08 |
20110218361 | METHOD FOR PRODUCING COMPOUND FOR PREPARATION OF ANTI-PARKINSON'S DISEASE DRUG - The present invention provides a method for producing a compound of formula (I), which is used for preparing anti-Parkinson's disease drugs, rasagiline and rasagiline mesylate. | 2011-09-08 |
20110218362 | Fixed Bed Hydrogenation Of Fatty Nitriles To Fatty Amines - A process for the fixed bed hydrogenation of unsaturated fatty nitriles to fatty amines with a fixed bed Raney-type Ni/Al, Co/Al or Ni/Co/Al catalyst in the liquid phase, the trickle phase or any type of fatty nitrile aerosol. | 2011-09-08 |
20110218363 | METHOD FOR PRODUCING ALKENYL MERCAPTAN - The present invention relates to a process for producing an alkenyl mercaptan (2), comprising reacting an alkenyl halide (1) with an alkali hydrosulfide, wherein the reaction is carried out in the presence of a disulfide (3) in an amount of 0.5 part by weight or more based on 100 parts by weight of the total amount of the alkenyl halide (1) and the alkenyl mercaptan (2). | 2011-09-08 |
20110218364 | Synthesis and Use of Intermetallic Iron Palladium Nanoparticle Compositions - An intermetallic magnetic compound of iron oxide and palladium with a nanometer particle size is disclosed, together with a method of making magnetic nanoparticles that include an intermetallic bond between palladium and iron-oxide. Additionally, a method is disclosed of catalyzing an organic reaction by contacting the organic reagents with an intermetallic magnetic compound of iron oxide and palladium that has nanometer particle size in an amount sufficient to catalyze the organic reaction. | 2011-09-08 |
20110218365 | ENGINEERED LIGHT-EMITTING REPORTER GENES AND METHODS OF USE - Compositions and methods are provided for enhanced expression of light emitting reporters. Such reporters are used in methods for monitoring cultures for production of target compounds. Additionally, methods are provided for the use of light emitting reporter systems and other reporter systems for selecting desired traits in an organism and for identifying or optimizing culture conditions. | 2011-09-08 |
20110218366 | PROCESS FOR THE ALKYLATION OF BENZENE WITH ISOPROPANOL OR BLENDS OF ISOPROPANOL AND PROPYLENE - The invention relates to a process for the alkylation of benzene with isopropanol (IPA) as alkylating agent, or blends of isopropanol and propylene, which comprises effecting said reaction completely in gaseous phase and in the presence of a catalytic system containing a zeolite belonging to the MTW family. | 2011-09-08 |
20110218367 | PROCESS FOR PRODUCING 2-PROPANOL - The invention provides processes for producing 2-propanol with higher purity than heretofore possible while suppressing the by-production of impurities. | 2011-09-08 |
20110218368 | METHOD FOR REDUCING THE FORMATION OF BY-PRODUCT DINITROBENZENE IN THE PRODUCTION OF MONONITROBENZENE - A method for making mononitrobenzene using a plug flow reactor train. Benzene, nitric acid and sulfuric acid are introduced into the reactor and produced mononitrobenzene is removed at an outlet end. All of the benzene and at least part of the sulfuric acid are introduced at the inlet end of the reactor. A first portion of the nitric acid is introduced by a first nitric acid feed into the inlet end and a second portion of the nitric acid is introduced at one or more additional feeds that are spaced between the inlet end and the outlet end. The method results in reduced formation of by-product dinitrobenzene, improving the reaction yield of mononitrobenzene while avoiding the need for a distillation step. | 2011-09-08 |
20110218369 | PROCESS FOR THE MANUFACTURE OF HYDROFLUOROOLEFINS - The invention relates to a process for manufacturing 1,1,1,2-tetrafluoropropene (1234yf, CF | 2011-09-08 |
20110218370 | PROCESS FOR THE MANUFACTURE OF HYDROCHLOROFLUOROOLEFINS - The present invention provides a process for the manufacture of trans 1-chloro-3,3,3-trifluoropropene (E- | 2011-09-08 |
20110218371 | Stabilizers for the Stabilization of Unsaturated Hydrocarbon-Based Precursor - A stabilized composition consists essentially of unsaturated hydrocarbon-based materials, and a stabilizer selected from the group consisting of a hydroxybenzophenone and a nitroxyl radical based stabilizer. A method for stabilizing unsaturated hydrocarbon-based precursor material against the polymerization comprises providing a stabilizer selected from the group consisting of a hydroxybenzophenone and a nitroxyl radical based stabilizer. | 2011-09-08 |
20110218372 | PROCESSES AND SYSTEMS FOR THE STAGED SYNTHESIS OF ALKYL BROMIDES - Processes and systems for synthesizing alkyl bromides to hydrocarbon products, such as high molecular weight hydrocarbons, olefins or mixtures thereof, wherein one or more streams of alkyl bromides may be synthesized in sequential or concurrent stages at different temperatures. The catalyst used in the synthesis stages may be the same or different and at least in one instance is chosen to form hydrocarbon products having a significant C | 2011-09-08 |
20110218373 | PROCESSES FOR PRODUCING AT LEAST ONE LIGHT OLEFIN - A process for producing at least one light olefin comprising: (a) contacting a first raw material comprising methanol with a least one catalyst comprising at least one silicon-aluminophosphate molecular sieve in a first reaction zone to produce a product stream I comprising at least one light olefin and at least one inactivated catalyst; (b) transporting the at least one inactivated catalyst to a first regeneration zone to produce at least one first regenerated catalyst, and transporting a portion of the at least one first regenerated catalyst to the first reaction zone, wherein the at least one first regenerated catalyst comprises a carbon deposit present in an amount ranging from about 0.8% to about 2.5% by weight relative to the total weight of the at least one first regenerated catalyst; (c) transporting another portion of the at least one first regenerated catalyst to a second regeneration zone to obtain at least one second regenerated catalyst, wherein the at least one second regenerated catalyst comprises a carbon deposit present in amount of less than about 0.2% by weight relative to the total weight of the at least one second regenerated catalyst; and (d) transporting the at least one second regenerated catalyst to a second reaction zone, and contacting the at least one second regenerated catalyst with a second raw material comprising C4 olefins to produce a product stream II comprising at least one light olefin. | 2011-09-08 |
20110218374 | PROCESSES AND SYSTEMS FOR THE STAGED SYNTHESIS OF ALKYL BROMIDES - Processes and systems for synthesizing hydrocarbon products, such as high molecular weight hydrocarbons, olefins or mixtures thereof, from alkyl bromides wherein one or more streams of alkyl bromides may be reacted in sequential or concurrent stages at different temperatures. The catalyst used in the synthesis stages may be the same or different and at least in one instance is chosen to form hydrocarbon products having a significant C | 2011-09-08 |
20110218375 | HYDROCARBON SYNTHESIS - A method of synthesizing hydrocarbons from smaller hydrocarbons includes the steps of hydrocarbon halogenation, simultaneous oligomerization and hydrogen halide neutralization, and product recovery, with a metal-oxygen cataloreactant used to facilitate carbon-carbon coupling. Treatment with air or oxygen liberates halogen and regenerates the cataloreactant. | 2011-09-08 |
20110218376 | PROCESS FOR PRODUCING HYDROCARBON OIL - The method for manufacturing a hydrocarbon oil of the present invention comprises a first step wherein a plurality of reaction zones filled with a specific catalyst is disposed in series and a feedstock oil containing an oxygen-containing hydrocarbon compound derived from an animal or vegetable oil is supplied and hydrotreated under the conditions of a hydrogen pressure of 1 MPa or more and 10 MPa or less in each of the reaction zones; and a second step wherein hydrogen, hydrogen sulfide, carbon dioxide and water are removed from a product to be treated obtained in the first step to obtain a hydrocarbon oil. Among the plurality of reaction zones, the inlet temperature of the reaction zone disposed on the most upstream side is 150° C. or more and 250° C. or less, the inlet temperature of the second most upstream reaction zone or below is equal to or higher than the condensation temperature of water, and the outlet temperature of the reaction zone disposed on the most downstream side is 260° C. or more and 360° C. or less. The feedstock oil comprises a recycled oil containing a specific amount of a part of the hydrocarbon oil obtained in the second step and a specific amount of a sulfur-containing hydrocarbon compound. | 2011-09-08 |
20110218377 | Method for solidifying and stabilizing waste acid - The present invention discloses a method for solidifying and stabilizing waste acid including steps of condensing waste acid containing phosphoric acid to reduce the volume; mixing the condensed waste acid with waste acid containing fluoroboric acid to solidify and stabilize the mixed waste acid. The pH of the mixed acid is adjusted by adding barium hydroxide as a neutralizer. The efficiency of solidifying waste acid can be improved by partially granulating and by adding solidifying agent indirectly. The method of the present invention can prevent intensely exothermic reaction caused by adding solidifying agents. Furthermore, the method of the present invention is controlled in a temperature of 30 to 45° C. to improve the polymerization of the mixed waste acid so that the efficiency of solidification thereof can be also improved. | 2011-09-08 |
20110218378 | OFF-PLANET WASTE DISPOSAL SYSTEM AND METHOD - Systems and methods are provided herein that provide for off-planet waste disposal including elevating waste into space via a space elevator and projecting the waste into the sun so as to dispose of the waste. | 2011-09-08 |
20110218379 | EPITOPES DERIVED FROM SATB2 AND USES THEREOF - The present invention relates to an affinity ligand capable of selective interaction with an epitope sequence consisting of 47 amino acids or less and comprising the amino acid sequence of SEQ ID NO:1 and/or SEQ ID NO:2. Further, it relates to a polypeptide consisting of the epitope sequence and to uses of the affinity ligand and the polypeptide. | 2011-09-08 |
20110218380 | Magnetic nanoparticle and group of nanoparticles - For particularly effective stem cell therapy a nanoparticle is provided. The nanoparticle has a first element consisting of a magnetic material, a support or envelope element consisting of a biodegradable material, a first substance containing an x-ray contrast agent, and a second substance containing stem cells. The stem cells are embodied such that they can be used for angiogenesis or for myogenesis. | 2011-09-08 |
20110218381 | Magnetic Stimulation coils with electrically conducting structures - The present invention introduces a novel apparatus ( | 2011-09-08 |
20110218382 | Auto-regulated R-Wave Synchronized Intraventricular Balloon Pump Heart Assist Device - Embodiments of the disclosed technology comprise an intraventricular balloon pump to help a dilated heart or ventricle push forward the stagnant stroke volume to the systemic circulation. The balloon fills simultaneously with the contraction of the ventricle. Since blood finds its way of least resistance, the easiest exit is through the aortic valve, against a closed mitral valve. The system is designed to be totally implantable, with a less invasive insertion and maintenance procedure than is known in the prior art. | 2011-09-08 |
20110218383 | PORTABLE CONTROLLER AND POWER SOURCE FOR MECHANICAL CIRCULATION SUPPORT SYSTEMS - A portable external device for a mechanical circulation support system includes first and second power sources, e.g. batteries and control electronics for redundant uninterrupted operation of an implantable blood pump. The control and power source module may be configured for variable form factors to accommodate a variety of wearable configurations for patient convenience and comfort. | 2011-09-08 |
20110218384 | PORTABLE CONTROLLER WITH INTEGRAL POWER SOURCE FOR MECHANICAL CIRCULATION SUPPORT SYSTEMS - A portable external device for a mechanical circulation support system includes first and second power sources, e.g. batteries and control electronics for redundant uninterrupted operation of an implantable blood pump. The control and power source module may be configured to accommodate a variety of wearable configurations for patient convenience and comfort. | 2011-09-08 |
20110218385 | PORTABLE CONTROLLER WITH INTEGRAL POWER SOURCE FOR MECHANICAL CIRCULATION SUPPORT SYSTEMS - A portable external device for a mechanical circulation support system includes first and second power sources, e.g. batteries and control electronics for redundant uninterrupted operation of an implantable blood pump. The control and power source module may be configured to accommodate a variety of wearable configurations for patient convenience and comfort. | 2011-09-08 |
20110218386 | Incus Replacement Partial Ossicular Replacement Prosthesis - An ossicular prosthesis is described which includes an elongated prosthesis member having a proximal end and a distal end. A cochlea striker mass is at the distal end of the prosthesis member and includes an outer striking surface for coupling vibration of the striker mass to an outer cochlea surface of a recipient patient. A locking clamp is at the proximal end of the prosthesis member and includes a clamp strap having a fixed end and a free end, and a locking head at the fixed end of the clamp strap which has a strap opening for insertion of the free end of the clamp strap. The clamp strap passes around an ossicle of the middle ear in a closed loop and is fixedly engaged by the locking head such that acoustic vibration of the ossicle is coupled by the prosthesis member to the cochlea surface. | 2011-09-08 |
20110218387 | ANCHORS FOR USE IN MEDICAL APPLICATIONS - An anchor system and associated method for manipulating, approximating or compressing tissues and anatomical or other structures in medical applications for the purpose of treating diseases or disorders or other purposes. The anchor includes one or more elastic wing and fin structures extending radially from the anchor's body. | 2011-09-08 |
20110218388 | Ring Magnet for Obesity Management - A system and method for restricting an anatomical passageway includes a plurality of ring magnet pieces. Each of the plurality of ring magnet pieces has an inner and outer surface, and a pair of magnetic end sections between the outer surface and the inner surface, each end section having a characteristic magnetic field arrangement. An insert includes at least one of a magnet and a magnetic material. The ring magnet pieces are capable of forming, due to their magnetic field arrangements, an enclosed ring around an anatomical passageway. The insert is magnetically held in place by the ring magnet pieces when positioned in the anatomical passageway. | 2011-09-08 |
20110218389 | Device for sealing and drainage of a natural or artificial intestinal outlet - The invention relates to a device for sealing and draining an intestinal outlet, the device comprising an inflatable balloon of a generally toroidal structure, whose two ends extend one inside the other, creating a sealed-off volume inside the balloon, whereby the filling of the volume can be adjusted from outside and a draining lumen radially inside the inner layer of the balloon, the outer layer of the tube comprising a radially expanded intra-rectal device which is placed inside the rectum or the intestine of a patient during use, and comprising a trans-anal device which extends through the anus of the patient or his abdominal wall, and a stiffening sleeve element positioned inside the draining lumen of the device, keeping the lumen open and facilitating the uptake and passage of feces through the intra-rectal segment of the draining lumen. | 2011-09-08 |
20110218390 | Specimen manipulation device for micro manipulation and biopsy in assisted reproduction and in vitro fertilization - A container or dish used for the micro manipulation, micro injection, biopsy and fertilization of oocyte and embryo culture. The dish allows the user to more readily perform procedures used to fertilize oocyte, such as intracytoplasmic sperm injection (ICSI), biopsy embryos and perform additional procedures in used in assisted reproductive techniques (ART), human reproduction and in vitro fertilization (IVF) techniques. The invention will allow ease in use, the reduction in the number of micro tools used in the procedure, as opposed to conventional dishes and procedures, and will allow the user to more readily locate the oocytes and embryos to be handled and worked on. The invention will add repetitiveness, consistency and may result in better results and outcome of the procedures. The invention will also give the user a more ergonomically correct dish for these types of procedures and related protocols. | 2011-09-08 |
20110218391 | METHOD FOR MONITORING ESTRUS AND OVULATION OF ANIMALS, AND FOR PLANNING A USEFUL FERTILIZATION TIME ZONE AND A PREFERRED FERTILIZATION TIME ZONE - Estrus of animals and particularly sows is determined for planning of a preferred time period of insemination by a sensing system arranged to detect standing of the animal. Data from the sensing system is collected and analyzed using an algorithm and information that is displayed on an indicating system to provide an indication to a worker of the time period of estrus and ovulation and of a useful insemination time period and a preferred insemination time period of the animal. The indicating system includes a countdown clock to the preferred time period of insemination. In the event that the insemination fails, an indication is provided about whether the actual time of insemination occurred at the preferred time of insemination indicated to the worker. When estrus is completed, a confidence level is provided about the likelihood of success based on the position of the actual time of insemination relative to ovulation. | 2011-09-08 |
20110218392 | IMPLANTABLE BOTTOM EXIT PORT - The present invention provides a system for attaching a fluid access port to a patient. The system generally comprises an implantable access port with a bottom exit port and method for attaching an access port to a patient. In addition, a tube guard, flexible tube exit port, tissue guard, and porous coupling member are disclosed. | 2011-09-08 |
20110218393 | MEDICAL DEVICE POSITIONING ASSEMBLIES AND METHODS - A medical retrieval device of an embodiment of the present disclosure includes an assembly for positioning a medical device includes a sleeve having a lumen configured to accept a medical device, and a tab. The tab includes a distal portion and a proximal portion. The distal portion is configured to receive the sleeve for positioning the sleeve proximate the proximal portion. The proximal portion is configured such that severing the tab along the proximal portion maintains the tab in one piece. | 2011-09-08 |
20110218394 | APPARATUS AND METHOD FOR TREATING GERD - An apparatus for the treatment of acid reflux disease comprising two or more movement restriction device segments adapted to be assembled movement restriction device of a controlled size. The assembled movement restriction device can at least partly be invaginated by a patient's stomach fundus wall. A substantial part of the outer surface of the movement restriction device is adapted to rest against the stomach wall without injuring the latter in a position between the patient's diaphragm and at least a portion of the lower part of the invaginated stomach fundus wall, such that movement of the cardiac notch of the patient's stomach towards the patient's diaphragm is restricted, to thereby prevent the cardia from sliding through the patient's diaphragm opening into the patient's thorax, so as to maintain the supporting pressure against the patient's cardia sphincter muscle exerted from the patient's abdomen. | 2011-09-08 |
20110218397 | IMAGE PROCESSING SYSTEM, EXTERNAL DEVICE AND IMAGE PROCESSING METHOD - An image processing method includes the steps of: receiving image data from a body-insertable apparatus having a plurality of imaging units that captures an image of inside of a subject and generates image data and an identification information adding unit that adds identification information for identifying an imaging unit that generates the image data to the image data; displaying a list of the selected image data by the identification information; and switching image data to be displayed in the list displaying step from image data of the one identification information being displayed to image data of the other identification information. | 2011-09-08 |
20110218398 | IMAGE PROCESSING SYSTEM, IMAGING DEVICE, RECEIVING DEVICE AND IMAGE DISPLAY DEVICE - An image processing system includes an image generation unit that has two observation modes of a first observation mode for capturing an image under illumination by a first light source and a second observation mode for capturing an image under illumination by a second light source different from the first light source and generates an image to be displayed based on the image captured by selecting one of the observation modes; a brightness detection unit that detects brightness of the image captured in one observation mode; and a control unit that controls an exposure operation or image processing in the other observation mode performed subsequent to an observation in the one observation mode based on the brightness of the image detected by the brightness detection unit. | 2011-09-08 |
20110218399 | BODY-INSERTABLE APPARATUS AND IN-VIVO INFORMATION ACQUISITION SYSTEM - A body-insertable apparatus to be inserted into a subject includes an illumination unit that illuminates an inside of the subject; an imaging device having an effective pixel region that has a predetermined size and on which an optical image of the inside of the subject illuminated by the illumination unit is formed, and having an optical black region at which the optical image is shielded; and a light adjustment control unit that adjusts an amount of light from the illumination unit to the effective pixel region based on pixel values of the effective pixel region of an image signal and pixel values of the optical black region of the image signal. | 2011-09-08 |
20110218400 | SURGICAL INSTRUMENT WITH INTEGRATED WIRELESS CAMERA - A surgical instrument including an integrated wireless camera includes a handle assembly housing control circuitry. An elongated shaft extends from the handle assembly and includes an end effector disposed at a distal end thereof. An image sensor assembly is disposed toward the distal end of the elongated shaft and is electrically coupled to the control circuitry. The image sensor assembly is configured to convert an optical image into an electrical signal and communicate the electrical signal to the control circuitry. The control circuitry is configured to process the signal and wirelessly transmit the processed signal to a wireless receiver positioned remote of the surgical instrument. | 2011-09-08 |
20110218401 | PRESSURE-PROPELLED SYSTEM FOR BODY LUMEN - An apparatus for use with a biologically-compatible-fluid pressure source, the apparatus includes an elongate carrier, adapted to be inserted through a proximal opening of a body lumen, and a piston head coupled to a distal portion of the carrier. The piston head is adapted to form a pressure seal with a wall of the lumen after the carrier has been inserted into the lumen, and to be advanced distally through the body lumen in response to pressure from the fluid pressure source. The apparatus is configured to facilitate distal advancement of the piston head by facilitating passage of fluid out of the lumen from a site within the lumen distal to the piston head. | 2011-09-08 |
20110218402 | CAPSULE-TYPE MEDICAL DEVICE, POWER SUPPLY APPARATUS, AND POWER SUPPLY SYSTEM - Provided is a capsule-type endoscope that has a power receiving coil that wirelessly receives an electric power from outside a body of an individual to be examined, a processing circuit that performs predetermined processing, and an adjusting reactance section that is capable of adjusting a reactance that is connected to the power receiving coil. | 2011-09-08 |
20110218403 | SYSTEMS, METHODS AND COMPUTER-ACCESSIBLE MEDIUM WHICH PROVIDE MICROSCOPIC IMAGES OF AT LEAST ONE ANATOMICAL STRUCTURE AT A PARTICULAR RESOLUTION - Exemplary embodiments of probes, apparatus, systems and methods can be provided which provide at least one electro-magnetic radiation to at least one sample. For example, a plurality of axicon lenses can be provided which are configured to provide the electro-magnetic radiation(s) having at least partially annulus shape. In addition or alternatively, at least one optical arrangement can be provided which is configured to forward at least one radiation to the sample therethrough having at least partially circularly-symmetric pattern. For example, at least one first portion of the radiation transmitted through a circular section of the pattern can have an optical path-length that is different from an optical path-length of at least one second portion of the radiation transmitted through at least one other section of the pattern. | 2011-09-08 |
20110218404 | LIGHT SENSING SYSTEM AND ENDOSCOPE SYSTEM - The medical instrument includes an optical fiber sensor in which a plurality of FBG sections are formed, a reflector that forms reference light, a light source that outputs light by stepwise changing light beams of wavelengths of a predetermined interval, a coupler that splits light and generates interference light, a detection section that detects the interference light and a calculation section that calculates amounts of deformation of the FBG sections based on the detection result of the detection section. | 2011-09-08 |
20110218405 | SYSTEM AND METHOD FOR INTEGRATED QUANTIFIABLE DETECTION, DIAGNOSIS AND MONITORING OF DISEASE USING PATIENT RELATED TIME TREND DATA - A system comprising a memory device having a plurality of routines stored therein, a processor configured to execute the plurality of routines stored in the memory device, the plurality of routines comprising: a routine configured to effect, when executed, accessing of patient deviation scores indicative of differences between patient data and reference data representative of a population segment, wherein the patient deviation scores are derived from longitudinal data of the patient data such that the patient deviation scores include a plurality of sets of patient deviation scores, each set indicative of differences between patient data collected at a respective point in time and the reference data; a routine configured to effect, when executed, identifying a trend in the patient deviation scores for at least one clinical parameter; a routine configured to effect, when executed, generating of a report including a visual indication of the trend; and a routine configured to effect, when executed, outputting of the report. The report includes one or more views including Z, T, D, DT, and D feedback on T views, using image and non-image data. | 2011-09-08 |
20110218406 | Visual Display For Medical Monitor - The present disclosure describes a visual display for a medical monitor that may present a plurality of visualizations representative of physiological measurements. The visualizations may differ depending on whether the corresponding physiological parameter is within an expected range. The visualizations may include text, waveforms, images, video, and | 2011-09-08 |
20110218407 | METHOD AND APPARATUS TO MONITOR, ANALYZE AND OPTIMIZE PHYSIOLOGICAL STATE OF NUTRITION - A method and apparatus that for monitoring the physiological state of nutrition of an individual and adaptively analyze that data input to anticipate the individual's nutritional needs. A satiety meter may be employed to analyze a user's profile including nutritional state and determine when and how much a user should consume to prevent the onset of hunger and communicate is to a decision engine. The decision engine may generate and communicate a message to the user via the client device to prescribe prophylactic intake of nutrition to the individual prior to the onset of hunger based on the user's nutrition plan and/or regimen. | 2011-09-08 |
20110218408 | MEDICAL SYSTEM WITH IDENTIFICATION PATCH - A medical system that includes an identification patch having a memory that stores identification information associated with the patch. A monitoring device to be used with the identification patch interrogates the patch to obtain the identification information stored within the memory of the patch. The monitoring device determines whether the identification information is valid and, if so, measures values representing one or more parameters of the patient. If the identification information is not valid, monitoring device does not measure values representing the one or more parameters of the patient. | 2011-09-08 |
20110218409 | Device and method for measuring sleep apneas - A device is implemented as a functional patch, for measuring sleep apneas, which device includes: an acoustic sensor for measuring respiration and snoring noises; an optical sensor for measuring a saturation of oxygen in the blood of a human; and an adhesive patch which carries the acoustic sensor and the optical sensor. Analysis of the measuring signals and display of the sleep apneas are alternately performed in the functional patch or in an external unit, to which the data are transmitted wirelessly. | 2011-09-08 |
20110218410 | REMOTE PATIENT MANAGEMENT SYSTEM - The remote patient management system comprises: a computing device with a processor, a home infrastructure device comprising a patient display, a healthcare professional display, and a computer readable storage medium. The computer readable storage medium contains instructions that cause the processor to perform a method of displaying images on the patient display during a teleconsultation. The method comprises the steps of: accessing a patient record from a patient record database, creating a patient profile using the patient record, identifying a consultation aim using the patient profile, determining a list of topics using the consultation aim, creating a teleconsultation outline using the list of topics, selecting a set of images using the list of topics, displaying the teleconsultation outline on the healthcare professional display during the teleconsultation, and displaying the images on the patient display during the teleconsultation. | 2011-09-08 |
20110218411 | FLUID HANDLING CASSETTE SYSTEM FOR BODY FLUID ANALYZER - A fluid handling system for use in bodily fluid analysis. The system comprises a first fluid handling module configured to interface with a main instrument. The first fluid handling module has a first fluid handling network and the first fluid handling network includes an infusate passage and an infusion fluid pressure member suitable for moving fluid within the infusate passage. The fluid handling system also has a second fluid handling module separate from the first module which is configured to interface with the main instrument. The second fluid handling module has a second fluid handling network and at least one sample analysis cell which is accessible via the second fluid handling network. The first and second modules are configured to interconnect and provide fluid communication between the first and second fluid handling network and the sample cells. | 2011-09-08 |
20110218412 | LIVING-BODY COMPONENT MEASURING APPARATUS - A living-body component measuring apparatus measures a component of an inner tissue of a living body serving as an object to be measured by emitting laser light having two or more wavelengths from a light source and measuring reflected light of the laser light from the inner tissue of the living body. The living-body component measuring apparatus includes a beam splitter that changes optical paths of a part of the laser light and the reflected light, a reference-light measuring unit that measures, as reference light, the part of the laser light having the optical path changed by the beam splitter, a reflected-light measuring unit that measures the reflected light having the optical path changed by the beam splitter, and an analysis unit that analyzes the inner tissue by measuring a spectrum of the reflected light or the reference light. | 2011-09-08 |
20110218413 | Method and Apparatus for Non-invasive Fetal Oximetry - Method and apparatus to non-invasively measure fetal blood oxygen saturation levels. Optical sensors capable of producing and detecting multiple wavelengths of tissue penetrating light are placed on the surface of the maternal abdomen, and the light beams directed to pass through at least a portion of the uterus containing the fetus. The fetal heart rate is monitored by Doppler ultrasound, and pure maternal optical signal related to maternal arterial blood flow are also measured. The optical sensors collect composite signals containing both maternal and fetal hemoglobin absorption spectral data and modulated by their respective pulsatile blood flows. The composite signals processed in the time domain and frequency domain, the pure maternal pulsatile optical signal used to extract the maternal contribution to the composite signal, and the fetal pulsatile signal is used to lock onto and extract the fetal contribution to the composite signal, and a fetal blood oxygen level deduced. | 2011-09-08 |
20110218414 | SYSTEMS AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for processing sensor data, including calculating a rate of change of sensor data and/or determining an acceptability of sensor or reference data. | 2011-09-08 |
20110218415 | SYSTEM AND METHOD FOR DETECTING CARDIAC ARRHYTHMIAS FROM HEART NERVE ACTIVITY - A method has been developed that detects cardiac arrhythmia from intrinsic cardiac nerve signals obtained from a heart in a patient. The method includes sampling intrinsic cardiac nerve activity at a high sample rate, filtering the sampled signal with a high pass filter, comparing the filtered signal to a predetermined threshold, and initiating a therapeutic action in response to the filtered signal exceeding the predetermined threshold. The intrinsic cardiac nerve activity may be received through an electrode implanted on the heart or from an electrode inserted into the venous structure of the heart. | 2011-09-08 |
20110218416 | Needle Electrode Module - The invention is a needle electrode module, such as for use in neurodiagnostic monitoring, that helps minimize the risk of needle-stick injuries. As described, the needle electrode module includes a means for preventing the exposure of the distal end of a needle element until the module is placed against a surface. In an embodiment, the distal end of a needle element may be retracted into the needle electrode module when the needle electrode module is removed from the punctured surface and, once retracted, the distal end of the needle may be prevented from being accidentally re-exposed. Several embodiments use a mechanical mechanism to hold the distal end of the needle element in the retracted or exposed positions and a spring force to retract the distal end of the needle. Another embodiment uses suction to hold the distal end of the needle element in the exposed position and the force necessary to deform the body of the needle electrode module to retract the distal end of the needle element in the retracted position and maintain it in the retracted position. | 2011-09-08 |
20110218417 | BRAIN PROBE ADAPTED TO BE INTRODUCED THROUGH A CANULA - A bio-probe having a base and a tip and also including a set of at least four conductors extending longitudinally along the bio-probe, the conductors being coated with dielectric material. Also, at least four of the conductors define a spot where the dielectric material has been removed, thereby defining an electrical contact site. In addition, the bio-probe is less than 2.5 mm thick in its greatest transverse dimension along a longitudinal portion extending from the tip to a point 6 cm proximal of the tip. | 2011-09-08 |
20110218418 | IDENTIFICATION PATCH FOR A MEDICAL SYSTEM - A medical system that includes an identification patch having a memory that stores identification information associated with the patch. A monitoring device to be used with the identification patch interrogates the patch to obtain the identification information stored within the memory of the patch. The monitoring device determines whether the identification information is valid and, if so, measures values representing one or more parameters of the patient. If the identification information is not valid, monitoring device does not measure values representing the one or more parameters of the patient. | 2011-09-08 |